Avoro Capital Advisors LLC - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Vera Therapeutics, Inc. (VERA)

Filing Manager: Avoro Capital Advisors LLC
Reporting Manager: Avoro Capital Advisors LLC
Security: Vera Therapeutics, Inc. Class A Common Stock, $0.001 par value per share
Symbol: VERA
Shares outstanding: 63M shares
Disclosed Ownership: 5.61M shares
Ownership: 8.9%
Form type: SCHEDULE 13G/A
Date filed: 2/14/2025, 09:30 AM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Avoro Capital Advisors LLC	8.9%	5.61M	5.61M	0	/s/ Scott Epstein	Scott Epstein, Chief Financial Officer & Chief Compliance Officer
Behzad Aghazadeh	8.9%	5.61M	5.61M	0	/s/ Behzad Aghazadeh	Behzad Aghazadeh, Individually